Overall, these data demonstrated that the TME-induced FOXM1 upregulation is a vulnerability of OCSC, and can render them more responsive to PARPi, thus suggesting that a combinatorial treatment in the maintenance setting could successfully delay, or even prevent, tumor recurrence. The gene discussed is FOXM1; the disease is oral cavity squamous cell carcinoma.